Assessment of stenosis in a coronary artery using dual-source CT.


July 23, 2009 – Dual-energy CT used as a single examination might be promising for the integrative analysis of the coronary artery morphology and the myocardial blood supply and is in good agreement with angiography and SPECT, according to a study published in this month’s issue of The American Journal of Cardiology (volume 104, issue 3, pages 318-326, August 2009).

To evaluate the performance of dual-energy computed tomography (DECT) for integrative imaging of the coronary artery morphology and the myocardial blood supply, 36 patients (15 women, mean age 57 ± 11 years) with equivocal or incongruous single photon emission CT (SPECT) results were investigated by a single-contrast medium-enhanced, retrospectively electrocardiographic-gated, DECT scan with simultaneous acquisition of high and low X-ray spectra. Thirteen patients subsequently underwent invasive coronary angiography. The DECT data were used to reconstruct anatomic coronary CT angiographic images and to map the myocardial iodine distribution within the left ventricular myocardium.

Two independent observers analyzed all DECT studies for stenosis and myocardial iodine defects. A segmental comparison was performed between the stress/rest SPECT perfusion defects and DECT iodine defects and between the angiography and coronary CT angiographic findings for stenosis. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were estimated.

Overall, researchers said DECT had 92 percent sensitivity and 93 percent specificity, with 93 percent accuracy for detecting any type of myocardial perfusion defect seen on SPECT. Contrast defects at DECT correctly identified 85 (96 percent) of 89 fixed and 60 (88 percent) of 68 reversible myocardial perfusion defects. Compared with angiography, coronary CT angiography had 90 percent sensitivity, 94 percent specificity, and 93 percent accuracy for the detection of more than 50 percent stenosis.

The study was conducted by the Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston; the Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston; the Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore; and the Department of Radiology, University of Navarra, Pamplona, Spain.

For more information: www.ajconline.org


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Artificial Intelligence

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Subscribe Now